"Methylnitrosourea" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.
| Descriptor ID |
D008770
|
| MeSH Number(s) |
D02.654.692.480 D02.948.594.490
|
| Concept/Terms |
Methylnitrosourea- Methylnitrosourea
- Nitrosomethylurea
- N-Methyl-N-nitrosourea
- N Methyl N nitrosourea
|
Below are MeSH descriptors whose meaning is more general than "Methylnitrosourea".
Below are MeSH descriptors whose meaning is more specific than "Methylnitrosourea".
This graph shows the total number of publications written about "Methylnitrosourea" by people in this website by year, and whether "Methylnitrosourea" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methylnitrosourea" by people in Profiles.
-
Stearns V, Mori T, Jacobs LK, Khouri NF, Gabrielson E, Yoshida T, Kominsky SL, Huso DL, Jeter S, Powers P, Tarpinian K, Brown RJ, Lange JR, Rudek MA, Zhang Z, Tsangaris TN, Sukumar S. Preclinical and clinical evaluation of intraductally administered agents in early breast cancer. Sci Transl Med. 2011 Oct 26; 3(106):106ra108.
-
Guler G, Iliopoulos D, Han SY, Fong LY, Lubet RA, Grubbs CJ, Huebner K. Hypermethylation patterns in the Fhit regulatory region are tissue specific. Mol Carcinog. 2005 Jul; 43(3):175-81.
-
Mizumoto K, Farber JL. Growth inhibition and cell killing by N-methyl-N-nitrosourea: metabolic alterations that accompany poly(ADP-ribosyl)ation. Arch Biochem Biophys. 1995 Jun 01; 319(2):512-8.
-
Mizumoto K, Rothman RJ, Farber JL. Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide. Mol Pharmacol. 1994 Nov; 46(5):890-5.
-
Anzano MA, Smith JM, Uskokovic MR, Peer CW, Mullen LT, Letterio JJ, Welsh MC, Shrader MW, Logsdon DL, Driver CL, et al. 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res. 1994 Apr 01; 54(7):1653-6.